Quality Control  
   
  Our New Products  
   
  Our Contacts  
  Office :-  
  328-329, Paradise Complex
Sayajigunj, Baroda 390 005,
India
91-265-2362319 / 2362966, 6641924, 6457170
91 - 265 - 2226 093
 
     
 
  Reg. Office :-  
  161
Kika Street
Gulabvadi Mumbai-400004
Maharashtra
 
     
  Factory :-  
  Plot No.165/P
At. Vadadala
Tal. Savli, Dist Baroda 391520
India
91 - 2667 - 2510522
 
     
 
BUSINESS DEVELPMENT & PARTNERSHIPS :

Business Development & Partnerships

Rekvina pharmaceuticals, India's fastest growing pharmaceutical company, headquartered in India, is an integrated company, producing a wide range of quality, affordable medicines, trusted by healthcare professionals and patients across geographies. The Company has manufacturing operations in 6 states with a ground presence of more than 150 Medical Sales Representatives and its products are available all over countries. The Company is driven by its ambition to achieve Rs. 100 crore Sales by 2012 and be amongst the top players. To translate these objectives into reality and to optimize value creation, the Company has adopted a multi-pronged strategy. strong emphasis on brand marketing in India, entering high potential new markets with value added product offerings, are the major thrust areas. Successful business development transactions form a key component of it's business strategy.

In each of our partnerships, we strive to build enduring, mutually beneficial relationships that can produce positive results for both parties.

We are interested in sales and marketing partnerships and product acquisition opportunities in all the markets where we operate. We are exploring opportunities through Licensing and Alliances to draw maximum value from such arrangements. We continue to evaluate opportunities to add to our product basket, enhance our therapeutic presence and expand our distribution reach.

We are also interested in building winning drug discovery and development collaborations in the following therapeutic areas:

- Anti-infectives
- Inflammation & Respiratory
- Metabolic Diseases
- Oncology

In addition, we have active R&D programs in oral controlled release drug delivery systems and are looking for suitable partnerships. We are also actively evaluating options for acquiring new technology platforms to develop differentiated high margin products.

For business development, licensing, and partnership enquiries please contact:

Mr. Amit Shah
Director

Rekvina Pharmaceuticals
328/ Paradise complex Sayajigunj
Baroda, India
Phone: 091 (265) 236-2966
E-mail: amit@rekvina.com

 
   © Copyright 2008 Rekvina ® All Rights Reserved.